Investor

EDBI

6 portfolio companies tracked · $1.67B in latest raises

Overview

1

  • EDBI is the investment arm of Singapore's Economic Development Board, focusing on technology investments that support Singapore's economic development strategy. The firm invests in companies across various technology sectors including IT, healthcare, clean technology, and advanced manufacturing. EDBI typically invests in growth-stage companies and aims to facilitate business development opportunities in Singapore and Asia.

Stages

3

Series A Series B Growth

Sectors

6

Information technology Healthcare Clean Advanced manufacturing

Geographic focus

2

Asia Singapore

Portfolio companies

6

Companies from this investor’s TAAFT profile, ranked by latest known raise. Round details come from our company catalog.

Companies
6
Latest raises tracked
$1.67B
With round data
6
Stages seen
Series E+ ×3 Series C ×2 Series E
  • AlphaSense

    Financial · United States

    $650M raised
    Series E+ Closed 8 investors 7 rounds AI-native
    Post-money
    $4B
    Employees
    2.5k

    Announced 11 Jun 2024 · Leads: BDT & MSD Partners, Viking Global Investors

    Company Round details 1 tool in catalog
  • DataRobot

    Data Infrastructure and Analytics · United States

    $300M raised
    Series E+ Closed 4 investors 8 rounds AI-native
    Post-money
    $6.30B
    Employees
    835

    Announced 27 Jul 2021 · Leads: Altimeter Capital, Tiger Global Management

    Company Round details 3 tools in catalog
  • d-Matrix

    Computer Hardware Manufacturing

    $275M raised
    Series C Announced 9 investors
    Post-money
    $2B

    Announced 12 Nov 2025

  • Horizon3

    Cybersecurity · United States

    $250M raised
    Series E Announced 14 investors AI-native
    Post-money
    $2B

    Announced 03 Aug 2026 · Leads: NEA, NightDragon

    Company Round details 1 tool in catalog
  • Locus Robotics

    Robotics · United States

    $117M raised
    Series E+ Closed 11 investors 7 rounds AI-native
    Post-money
    $2B
    Employees
    485

    Announced 28 Nov 2022 · Leads: G2 Venture Partners, Goldman Sachs

    Company Round details 1 tool in catalog
  • Iterative Health

    Pharmaceutical Manufacturing · United States

    $77M raised
    Series C Announced 5 investors AI-native
    Valuation
    $1.30B

    Announced 01 May 2026 · Leads: Google Ventures